Search

everythinglearnresearchcommunity

for

Search:↓

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Most cases of visible blood in urine resolve on their own, but severe cases may need treatment.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Doctors should prescribe cheaper, off-label medication and teach patients how to use it to save money ethically.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Finasteride treats baldness but may cause lasting sexual side effects.

Taking alfuzosin and finasteride together caused temporary vision loss in a glaucoma patient, but switching to tamsulosin helped.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

A new compound that could treat various androgen-related conditions was created and analyzed.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

The document discusses new insights into how hormones affect male sexual health and related conditions.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

Finasteride discontinuation increases sperm count in men.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.